Safety and Efficacy of E/C/F/TDF Versus RTV-Boosted ATV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment-Naive Women
Public ClinicalTrials.gov record NCT01705574. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to evaluate the efficacy of a regimen containing elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate (E/C/F/TDF) versus ritonavir (RTV)-boosted atazanavir (ATV/r) plus emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) in HIV-1 infected, antiretroviral treatment-naive adult women.
Study identification
- NCT ID
- NCT01705574
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 583 participants
Conditions and interventions
Conditions
Interventions
- E/C/F/TDF Drug
- ATV Drug
- RTV Drug
- FTC/TDF Drug
- E/C/F/TDF Placebo Drug
- ATV Placebo Drug
- RTV Placebo Drug
- FTC/TDF Placebo Drug
- E/C/F/TAF Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 24, 2012 (Actual)
- Primary completion
- Feb 9, 2015 (Actual)
- Completion
- Sep 6, 2018 (Actual)
- Last update posted
- Sep 20, 2019
2012 – 2018
United States locations
- U.S. sites
- 41
- U.S. states
- 15
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Southern California AIDS Clinical Trials Group | Los Angeles | California | 90033 | — |
| University of California, Davis Medical Center | Sacramento | California | 95817 | — |
| Whitman-Walker Health | Washington D.C. | District of Columbia | 20009 | — |
| George Washington University Medical Faculty Associates | Washington D.C. | District of Columbia | 20037 | — |
| Midway Immunology and Research Center | Ft. Pierce | Florida | 34982 | — |
| University of Miami | Miami | Florida | 33136 | — |
| Orlando Immunology Center | Orlando | Florida | 32803 | — |
| IDOCF/ValuhealthMD | Orlando | Florida | 32806 | — |
| St. Joseph's Hospital Comprehensive Research Institute | Tampa | Florida | 33614 | — |
| Triple O Research Institute, P.A. | West Palm Beach | Florida | 33401 | — |
| AIDS Research Consortium of Atlanta | Atlanta | Georgia | 30308 | — |
| Emory HIV/AIDS Clinical Trials Unit | Atlanta | Georgia | 30308 | — |
| Infectious Disease Specialists of Atlanta | Decatur | Georgia | 30033 | — |
| Mercer University Mercer Medicine | Macon | Georgia | 31201 | — |
| Chatham County Health Daprtment | Savannah | Georgia | 31401 | — |
| University of Louisville | Louisville | Kentucky | 40202 | — |
| LSUHSC HIV Out-Patient Clinic Research | New Orleans | Louisiana | 70119 | — |
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | — |
| The Research Institute | Springfield | Massachusetts | 01105 | — |
| Saint Michael's Medical Center | Newark | New Jersey | 07102 | — |
| New Jersey Medical School | Newark | New Jersey | 07103 | — |
| New York Hospital Queens | Flushing | New York | 01135 | — |
| University of Rochester | Rochester | New York | 14642 | — |
| Montefiore Medical Center | The Bronx | New York | 10040 | — |
| University of North Carolina AIDS Clinical Trials Unit | Chapel Hill | North Carolina | 27599 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| East Carolina University The Brody School of Medicine Div. of Infectious Diseases | Greenville | North Carolina | 27834 | — |
| Wake Forest University Health Sciences | Winston-Salem | North Carolina | 27157 | — |
| Wexner Medical Center at the Ohio State University | Columbus | Ohio | 43210 | — |
| The University of Toledo Medical Center | Toledo | Ohio | 43614 | — |
| Lehigh Valley Health Network | Allentown | Pennsylvania | 18102 | — |
| Philadelphia FIGHT | Philadelphia | Pennsylvania | 19107 | — |
| Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | — |
| Temple University Hospital- Internal General Medicine | Philadelphia | Pennsylvania | 19140 | — |
| The Miriam Hospital | Providence | Rhode Island | 02906 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| Central Texas Clinical Research | Austin | Texas | 78705 | — |
| UT - Physicians | Bellaire | Texas | 77401 | — |
| AIDS Arms, Inc./Trinity Health & Wellness Center | Dallas | Texas | 75208 | — |
| North Texas Infectious Diseases Consultants, PA | Dallas | Texas | 75208 | — |
| Therapeutic Concepts, PA | Houston | Texas | 77004 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 58 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01705574, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 20, 2019 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01705574 live on ClinicalTrials.gov.